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The C-terminal regions (CT) of Pfam PF04740 proteins share signiﬁcant sequence identity with the
toxic CdiA-CT effector domains of contact-dependent growth inhibition (CDI) systems. In accord
with this homology, we ﬁnd that several PF04740 CT domains inhibit cell growth when expressed
in Escherichia coli. This growth inhibition is speciﬁcally blocked by antitoxin proteins encoded
downstream of each PF04740 gene. The YobL-CT, YxiD-CT and YqcG-CT domains from Bacillus
subtilis 168 have cytotoxic RNase activities, which are neutralized by the binding of cognate YobK,
YxxD and YqcF antitoxin proteins, respectively. Our results show that PF04740 proteins represent
a new family of toxin/antitoxin pairs that are widely distributed in Gram-positive bacteria.
Structured summary of protein interactions:
YobK binds to YobL by pull down (View interaction)
YezG binds to YeeF by pull down (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Bacteria express a variety of systems that allow them to cooper-
ate and compete with one another in the environment. Contact-
dependent growth inhibition (CDI) is one such mechanism by
which some Gram-negative bacteria inhibit the growth of neigh-
boring cells upon direct cell-to-cell contact [1–3]. CDI is mediated
by the CdiB/CdiA two-partner secretion system. CdiA is the effector
protein of CDI, and its growth inhibition activity is contained with-
in the C-terminus (CdiA-CT). CdiA-CT sequences are highly variable
between CDI systems, implying that a variety of toxins are
deployed by inhibitor cells. All CDI loci also encode immunity pro-
teins, which speciﬁcally bind and inactivate cognate CdiA-CT tox-
ins to prevent autoinhibition. We recently reported on the
striking similarities between CdiA and Rhs (rearrangement hot-
spot) proteins, noting that some members of these two families
share C-terminal toxin domains [4]. Rhs systems also encode
immunity proteins that speciﬁcally neutralize the toxic effects of
cognate Rhs-CT domains [4]. During these studies, we discovered
that CdiA-CT sequences are also shared with other protein families,chemical Societies. Published by E
iences Technology Building,
5, United States. Fax: +1 805
s).including MafB proteins from Neisseria species, Ala-Pro rich
proteins fromMycobacterium species, and the Pfam PF04740 family
of putative transposases from Gram-positive bacteria. Each of
these families is characterized by a conserved N-terminal region
and variable C-terminal sequences. The observed homologies
suggest that MafB, Ala-Pro and PF04740 proteins contain variable
C-terminal toxin domains.
Here, we present evidence that PF04740 proteins constitute a
family of polymorphic toxins. PF04740 proteins are present in
many species of Bacillus and Listeria as well as some Clostridium
and Streptococcus species. Most of these species contain multiple
PF04740 proteins, each carrying a distinct CT region. Moreover,
the complement of PF04740 proteins varies considerably between
different strains of the same species. For example, Bacillus pumilus
ATCC 7061 and B. pumilus SAFR-032 each contain ﬁve PF04740 pro-
teins, but only one CT region is common to both strains. We exam-
ined the function of PF04740 CT domains from Bacillus subtilis 168
and Bacillus cereus ATCC 14579, and found that these proteins inhi-
bit cell growth when expressed inEscherichia coli. This growth inhi-
bition was speciﬁcally blocked by cognate antitoxin proteins,
which are encoded downstream of each PF04740 family member.
Analysis of nucleic acids from inhibited cells revealed that several
PF04740 CT domains possess RNase activities. Taken together
these results indicate that the PF04740 family constitutes a new
family of toxin–antitoxin proteins.lsevier B.V. All rights reserved.
Fig. 1. YobL-CT and YxiD-CT inhibit E. coli growth. (A) YobL-CT inhibits cell growth.
YobL-CT/YobK-DAS synthesis was induced in wild-type E. coli (clp+) and DclpX
DclpA cells with L-arabinose at the indicated time and cell growth monitored by
optical density at 600 nm (OD600). A construct expressing YobL-CT with the
His562Ala mutation (full-length numbering) was also tested. (B) YxiD-CT inhibits
cell growth. YxiD-CT/YxxD-DAS synthesis was induced in wild-type E. coli (clp+) and
DclpX DclpA cells and cell growth monitored as described in panel A. A construct
expressing YxiD-CT with the His548Ala mutation (full-length numbering) was also
tested.
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2.1. Plasmids, bacterial strains and growth conditions
All bacterial strains and plasmids are listed in Table S1. The
DclpX and DclpA alleles were obtained from the Keio collection
[5] and transduced into strain X90 using bacteriophage P1. The
genes encoding PF04740 CT domains and associated antitoxinFig. 2. YobL-CT and YxiD-CT are cytotoxic RNases. The synthesis of CT toxins and ssrA(DA
cells as described in Section 2. Constructs expressing YobL-CT with the His562Ala mutatio
(clp+). Cells were collected at the indicated times after induction and RNA isolated for ggenes were ampliﬁed from genomic DNA by PCR and ligated into
expression plasmids. PF04740 CT/antitoxin gene pairs were cloned
into plasmid pET21S [4] for the overproduction and puriﬁcation of
CT domains and His6-tagged antitoxin proteins (Table S1). Gene
pairs were also cloned into a derivative of plasmid pCH450 that
fuses an in-frame ssrA(DAS) coding sequence to the antitoxin
genes (Table S1) [4,6]. These latter constructs were used to test
for growth inhibition activity in E. coli clp+ cells. Individual anti-
toxin genes were cloned into plasmid pTrc2 [7] for use in growth
rescue experiments. All PCR primer sequences and plasmid
sequences are available upon request. E. coli strains were cultured
at 37 C with aeration in LBmedium supplemented with the appro-
priate antibiotics (150 lg/ml ampicillin and 12.5 lg/ml tetracy-
cline) to maintain plasmids. Synthesis of CT domains and
ssrA(DAS)-tagged antitoxins was induced with 0.2% L-arabinose.
2.2. Toxin–antitoxin binding studies
PF04740 CT domains and antitoxin proteins were puriﬁed as
native complexes, then isolated under denaturing conditions and
refolded as described [1,4]. Puriﬁed YobL-CT or YeeF-CT was mixed
with either YobK-His6 or YezG-His6 (10 lM ﬁnal concentration) in
binding buffer [20 mM sodium phosphate (pH 7.0), 400 mM NaCl,
0.05% Triton X-100, 14 mM b-ME] and incubated for 30 min at
room temperature. An aliquot of the mixture was removed for
analysis by SDS–PAGE. Ni2+-nitrilotriacetic acid (NTA) agarose
resin was then added and incubated at 4 C for 1.5 h. The resin
was collected by centrifugation and the supernatant removed as
the unbound fraction. After washing with binding buffer, resin-
bound proteins were eluted with binding buffer supplemented
with 250 mM imidazole.
2.3. RNA isolation and analysis
B. subtilis 168 and E. coli lysates were used for in vitro CT activity
assays. Cells were grown to mid-log phase, harvested by centrifu-
gation, washed once with ice-cold S30 buffer [10 mM Tris–acetate
(pH 7.0), 60 mM ammonium acetate, 10 mM magnesium acetate]
and then frozen at 80 C. Thawed E. coli cells were broken by pas-
sage through a French press at 20000 psi. B. subtilis cells were ﬁrst
treated with 2 mg/ml lysozyme in S30 buffer for 1 h before lysis by
French press. Lysates were cleared by centrifugation at 30000g
and adjusted to an RNA concentration of 100 lg/ml for in vitro
RNase assays. Puriﬁed PF04749 CT domains and/or antitoxin pro-
teins were added to lysates at 1 lM ﬁnal concentration. Reactions
were incubated at 37 C for 1 h, then extracted with guanidinium
isothiocyanate–phenol to isolate RNA for gel analysis [8].S)-tagged antitoxin proteins was induced in wild-type E. coli (clp+) and DclpX DclpA
n and YxiD-CT with the His548Ala mutation were also expressed in wild-type E. coli
el analysis. The gel migration positions of rRNAs and tRNAs are indicated.
0Fig. 3. PF04740 CT domains have RNase activities. PF04740 CTs and ssrA(DAS)-tagged antitoxin proteins was induced in wild-type E. coli (clp+) and DclpX DclpA cells as
described in Section 2. Cells were collected at the indicated times after induction and RNA isolated for gel analysis. The gel migration positions of rRNAs and tRNAs are
indicated.
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3.1. Identiﬁcation of PF04740 CT domains
BLAST analysis using CdiA-CT toxin domains revealed a new
class of homologues designated as Pfam PF04740 proteins (http://
pfam.sanger.ac.uk/family/PF04740). As an example, the CdiA-
CTEC869 from E. coli O157:H7 strain EC869 shares sequence identity
with the C-terminal regions of YwqJA (Uniprot B4AIN5) from B.
pumilus ATCC 7061 and Lin1451 (Q92BU3) from Listeria innocua
strain Clip11262 (Fig. S1A). PF04740 proteins are annotated as
transposases, but Zhang et al. have recently postulated that these
proteins have toxic nuclease activities based on bioinformatics
[9]. The regions downstream of ywqJA and lin1451 both encode
small proteins (BAT_3673 (B4AIN4) and Lin1450 (Q92BU4), respec-
tively) with weak homology to the CdiIEC869 immunity protein
(Fig. S1B). These observations suggest that the genes encoding
PF04740 proteins are associated with downstream immunity/anti-
toxin genes.
In general, Bacillus species contain several members of the
PF04740 family. For example, B. subtilis strain 168 contains six pre-
dicted PF04740 proteins: YobL (O34330), YokI (O31998), YeeF
(O31506), YqcG (P45942), YwqJ (P96722) and YxiD (P42296). These
proteins share a conserved N-terminal region, but the C-terminal
120–150 residues are variable (Fig. S2), analogous to CdiA and
Rhs proteins [1,4]. Moreover, the CT region of YeeF shares sequence
identity with CdiA-CTs from Burkholderia multivorans (B9CIC5,
B9BNB6), Pantoea ananatis (D4GL28) and Providencia alcalifaciens
(B6XC53); and the CT region of YxiD is related to the toxic RhsB-
CT (E0SIS2) from Dickeya dadantii 3937 [4]. Taken together, these
observations suggest that PF04740 proteins carry a variety of toxic
CT domains.
3.2. PF04740 CT domains have toxic RNase activity
Based on homology to CDI and Rhs systems [1,4], we predicted
that PF04740 proteins are encoded as toxin–antitoxin pairs. To test
this hypothesis, we focused on family members in B. subtilis 168.
We cloned the B. subtilis yobLK and yxiD–yxxD gene pairs under
control of the PBAD promoter on a plasmid vector that appends
the ssrA(DAS) peptide tag onto the C-terminus of the predicted
YobK and YxxD antitoxin proteins. Induction of both constructs ar-
rested the growth of wild-type E. coli, but not E. coli DclpX DclpA
mutant cells (Fig. 1), which are unable to degrade ssrA(DAS)-
tagged proteins efﬁciently [10]. These results indicate that YobK
and YxxD block the growth inhibitory activities of YobL and YxiD,
respectively. We isolated RNA from growth-arrested cells and
found that rRNA was cleaved upon activation of YobL and YxiD(Fig. 2). The YxiD-CT has a consensus HNH nuclease motif
[11,12], which was mutated (His548Ala) to test whether RNase
activity is required for growth inhibition. The resulting protein
lacked RNase activity and was no longer toxic to E. coli cells (Figs.
1 and 2). YobL-CT has a similar nuclease motif and mutation of
His562 to alanine ablated RNase activity and growth inhibition
(Figs. 1 and 2). We also tested YqcG-CT and the CT of BC_0920 from
B. cereus ATCC 14579, both of which lack nuclease motifs. These CT
domains inhibited E. coli growth and led to RNA degradation (Fig. 3
and not shown), indicating that several PF04740 CT domains have
toxic RNase activities.
3.3. Cognate antitoxin proteins block PF04740 activity
To determine if PF04740 antitoxins speciﬁcally block only cog-
nate toxin activity, we tested antitoxins for the ability to rescue
cells from PF04740 CT-mediated growth inhibition. We introduced
arabinose-inducible yobL/yobK-DAS, yxiD/yxxD-DAS, yqcG/yqcF-DAS
and yokI/yokJ-DAS constructs into E. coli cells that carry plasmid-
borne yobK, yxxD, yqcF or yokJ antitoxin genes, and selected for
transformants on LB agar supplemented with L-arabinose. Stable
transformants were only obtained when cells carried the cognate
antitoxin gene (Fig. 4). For example, plasmid-borne yobK permitted
transformation of the yobL/yobK-DAS construct, but not the other
three toxin constructs (Fig. 4). These results indicate that the
B. subtilis YobK, YxxD, YqcF and YokJ proteins all possess antitoxin
function that is speciﬁc for their cognate PF04740 toxins.
3.4. Antitoxin proteins bind cognate PF04740 proteins and block RNase
activity
In CDI systems, CdiI immunity proteins neutralize CdiA-CT
domains through direct binding interactions. To determine if anti-
toxins bind speciﬁcally to cognate PF04740 CT domains, we tested
whether untagged CT domains co-purify with His6-tagged antitox-
ins during Ni2+-afﬁnity chromatography. We incubated puriﬁed
YobK-His6 with either YobL-CT or YeeF-CT and found that only
the cognate YobL-CT co-puriﬁed with tagged YobK (Fig. 5).
Similarly, only the cognate YeeF-CT domain co-puriﬁed with
YezG-His6 antitoxin during Ni2+-afﬁnity chromatography (Fig. 5).
These results show that PF04740 CTs and antitoxins bind one an-
other in a speciﬁc manner.
Finally, we tested whether antitoxins speciﬁcally block RNase
activity. Puriﬁed YobL-CT and YxiD-CT both promoted RNA degra-
dation in E. coli cell lysates (Fig. 6A). Addition of cognate antitoxin
protein completely blocked RNase activity (Fig. 6A), consistent
with the experiments showing that antitoxin proteins prevent
growth inhibition. We also performed these assays with B. subtilis
Fig. 5. PF04740 CT domains bind speciﬁcally to cognate antitoxin proteins. His6-
tagged YobK and YezG were used as bait for the co-puriﬁcation of untagged YobL-
CT and YeeF-CT prey domains. CT/antitoxin protein mixtures (input) were
incubated with Ni2+-NTA agarose, and the free and resin-bound fractions isolated
for analysis by SDS–PAGE. The gel migration positions for molecular weight
standards (given in kDa) and each CT/antitoxin pair are indicated.
Fig. 4. Antitoxins speciﬁcally neutralize the toxicity of cognate PF04740 CT domains. Wild-type E. coli clp+ cells producing the YokJ, YobK, YxxD or YqcF antitoxins (labeled
columns) were incubated with the indicated PF04740 CT/DAS-tagged antitoxin expression plasmids (labeled rows), then plated onto LB agar plates (supplemented with
antibiotics and L-arabinose) to select transformants.
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RNase activity was blocked by cognate, but not non-cognate anti-
toxin (Fig. 6B), demonstrating the speciﬁcity of antitoxin function.
4. Discussion
Our results suggest that PF04740 proteins represent a new class
of bacterial toxin/antitoxin pairs, with each PF04740 gene followed
by a speciﬁc antitoxin gene. Although the PF04740 CT sequences
are quite divergent, several of these domains exhibit similar RNase
activities. This characteristic is reminiscent of the toxin–antitoxin
(TA) modules found throughout the eubacteria and archaea [13].
TA modules produce small toxins with divergent primary
sequences, but many of these toxins are nucleases that cleave
mRNA. However, the PF04740 toxin family is distinct from TAmod-
ules. TA systems are typically organized with the opposite gene or-
der with the antitoxin encoded upstream of the toxin. Moreover,
PF04740 toxins are signiﬁcantly larger than TA module toxins and
contain a conserved N-terminal region that deﬁnes the protein fam-
ily. Our data show that the PF04740 toxin activity resides in the var-
iable CT region, suggesting the N-terminus performs a function
required for all family members. The N-terminal region is predicted
to form an a-helical coiled-coil, and Zhang et al. have recently pre-
dicted that this domain is related of the ESAT-6/WXG100 superfam-
ily [9,14]. The ESAT-6/WXG100 motif is a secretion signal for the
type VII secretion systems of Mycobacterium and Bacillus species
[15–18]. Though this hypothesis has yet to be conﬁrmed experi-
mentally, it suggests that the PF04740 proteins are secreted into
the environment or perhaps delivered to other cells.
The PF04740proteins could be secreted for at least twopurposes.
Firstly, the PF04740 RNases could be released into the environment
to scavenge nucleosides for metabolism prior to sporulation. The
DegU–DegS regulon controls expressionof extracellular degradative
enzymes, which are secreted by B. subtilis during the transition from
exponential to stationary phase growth [19]. The PF04740 genes
yobL, yxiD and ywqJ genes are all members of the DegS–DegU
AB
Fig. 6. Antitoxin proteins speciﬁcally block PF04740 CT RNase activity. (A)
Antitoxins block RNase activity in an E. coli lysate. Lysate was treated with buffer
(mock) or the indicated puriﬁed proteins at 1 lM ﬁnal concentration. RNA was then
isolated for gel analysis. (B) Antitoxins block RNase activity in B. subtilis extracts.
The lysate was treated as described for panel A. The gel migration positions for
rRNAs and tRNAs are indicated.
136 L.E. Holberger et al. / FEBS Letters 586 (2012) 132–136regulon [20,21], consistent with a scavenging function. In addition,
the yqcG gene is under Spo0A control [22] and is therefore also
expressed during stationary phase. However, if PF04740 proteins
function as degradative nucleases, this raises the question of why
multiple, sequence-diverse enzymes are secreted when they have
nearly identical activities. A second possibility is that PF04740 pro-
teins function in growth competition analogous to CDI systems in
proteobacteria [1,3,23]. In this scenario, bacteriawithdifferent com-
plements of PF04740 proteins would compete with one another for
environmental niches. The resulting selective pressure could per-
haps account for the observed diversity in PF04740 toxin/antitoxin
sequences. We are actively testing these models to determine the
physiological function of these toxin/antitoxin proteins.
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